State Street’s Vyant Bio VYNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-15,038
Closed -$8.72K – 4807
2023
Q1
$8.72K Hold
15,038
– – ﹤0.01% 4751
2022
Q4
$10.6K Sell
15,038
-2
-0% -$3 ﹤0.01% 4800
2022
Q3
$42K Hold
15,040
– – ﹤0.01% 4694
2022
Q2
$68K Buy
15,040
+640
+4% +$2.81K ﹤0.01% 4658
2022
Q1
$103K Buy
14,400
+1,266
+10% +$7.36K ﹤0.01% 4634
2021
Q4
$89K Hold
13,134
– – ﹤0.01% 4604
2021
Q3
$153K Buy
13,134
+2,580
+24% +$35.7K ﹤0.01% 4445
2021
Q2
$197K Buy
+10,554
New +$197K ﹤0.01% 4216

Other funds holding VYNT

State Street's VYNT Position: Q2 2023 in Review

State Street sold out of Vyant Bio (VYNT) in Q2 2023, closing a stake of 15,038 shares — an estimated $8.72K sold.

State Street first reported a position in VYNT in Q2 2021 and held it in 8 quarters. The position peaked at $197K in Q2 2021. 1 fund tracked by Wall St. Rank holds VYNT as of Q2 2023.

  • State Street reported no remaining Vyant Bio position as of Q2 2023 after selling out during the quarter.
  • State Street sold 15,038 Vyant Bio shares in Q2 2023, an estimated $8.72K.
  • State Street first reported a position in Vyant Bio in Q2 2021 and held it in 8 quarters.
  • State Street's Vyant Bio position peaked at $197K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Vyant Bio as of Q2 2023.

Based on State Street's 13F filing for Q2 2023, filed 14 Aug 2023.